These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1557698)

  • 21. [Effect of 5-HT3 receptor antagonists on gastrointestinal motility].
    Yoshida N; Ito T; Karasawa T; Iwanaga H; Mizumoto A; Ito A
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):315-9. PubMed ID: 2562028
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation.
    Gozlan H; Schechter LE; Bolanos F; Emerit MB; Miquel MC; Nielsen M; Hamon M
    Eur J Pharmacol; 1989 Dec; 172(6):497-500. PubMed ID: 2533081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats.
    Knapp DJ; Pohorecky LA
    Pharmacol Biochem Behav; 1992 Apr; 41(4):847-50. PubMed ID: 1594653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.
    Rodgers RJ; Cole JC; Tredwell JM
    Psychopharmacology (Berl); 1995 Feb; 117(3):306-12. PubMed ID: 7770606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
    Young R; Glennon RA
    Eur J Pharmacol; 1992 Feb; 212(1):117-9. PubMed ID: 1555633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.
    Chojnacka-Wójcik E; Kłodzińska A; Dereń-Wesołek A
    Pol J Pharmacol; 1994; 46(5):423-8. PubMed ID: 7894529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine releasing effect of phenylbiguanide in rat striatal slices.
    Benuck M; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):666-72. PubMed ID: 1635590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists.
    Barnes JM; Barnes NM; Costall B; Domeney AM; Johnson DN; Kelly ME; Munson HR; Naylor RJ; Young R
    Pharmacol Biochem Behav; 1990 Dec; 37(4):717-27. PubMed ID: 2128757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
    Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
    Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
    Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study.
    Nomikos GG; Zis AP; Damsma G; Fibiger HC
    Neuropsychopharmacology; 1991 Jan; 4(1):65-9. PubMed ID: 1706182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.
    Andrews N; File SE
    Eur J Pharmacol; 1993 Apr; 235(1):109-12. PubMed ID: 8519271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of 5-hydroxytryptamine in the intestinal motor disturbances induced by mast cell degranulation in rats.
    Bueno L; Fargeas MJ; Theodorou V; Fioramonti J
    Eur J Pharmacol; 1991 Jan; 192(2):263-9. PubMed ID: 2032558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of indomethacin, renzapride, methysergide, ketanserin, granisetron and citalopram on serotonin-induced fluid accumulation in pig jejunum.
    Hansen MB; Thørboll JE; Beubler E; Skadhauge E
    Physiol Res; 1994; 43(2):83-93. PubMed ID: 7918343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of cyanide on the extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 5-hydroxyindoleacetic acid and inositol phospholipid breakdown in the brain.
    Cassel GE; Koch M; Tiger G
    Neurotoxicology; 1995; 16(1):73-82. PubMed ID: 7541518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?
    Andrews N; File SE
    Psychopharmacology (Berl); 1992; 108(3):333-7. PubMed ID: 1523283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride.
    Barnes NM; Costall B; Ironside JW; Naylor RJ
    J Pharm Pharmacol; 1988 Sep; 40(9):668. PubMed ID: 2907045
    [No Abstract]   [Full Text] [Related]  

  • 40. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
    Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.